News | July 18, 2022
India crosses ‘200 Crore’ COVID-19 vaccinations
PM congratulates citizens on crossing the 200 crore milestone of Covid vaccination drive
PM congratulates citizens on crossing the 200 crore milestone of Covid vaccination drive
Jublia (Efinaconazole) topical solution, 10% had annual sales of $292 million in the United States according to IQVIA data (IQVIA MAT May 2022).
George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.
The company plans to execute both these tenders at their API manufacturing unit located at Savli, Gujarat, India.
The GMP facility is equipped with state of art machinery for the needs of Global commercial requirements
The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.
The expansion at CDMO facility in South Haven, will bring a new 4,000-gallon multi-use reactor train consisting of glass lined and stainless-steel materials of construction
Plant is part of the company's CAD $30 million capital investment in the site
Subscribe To Our Newsletter & Stay Updated
